EXCISION REPAIR CROSS-COMPLEMENTING GROUP 1 (ERCC1) MAY PREDICT THE EFFICACY OF CHEMORADIOTHERAPY FOR BLADDER CANCER

被引：0
|
作者：
Kawashima, Atsunari
Nakayama, Masashi
Kakuta, Yoichi
Abe, Toyofumi
Sato, Mototaka
Hatano, Koji
Mukai, Masatoshi
Nagahara, Akira
Oka, Daizo
Nakai, Yasutomo
Takayama, Hitoshi
Yoshioka, Toshiaki
Hoshida, Yoshihiko
Itatani, Hiroaki
Nishimura, Kazuo
Nonomura, Norio
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.1206
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
510
引用
收藏
页码：E207 / E208
页数：2
相关论文
共 50 条
  • [1] Excision repair cross complementing group 1 (ERCC1) predicts the efficacy of chemoradiotherapy for invasive bladder cancer
    Kawashima, Atsunari
    Nakayama, Masashi
    Kakuta, Yoichi
    Abe, Toyofumi
    Sato, Mototaka
    Hatano, Koji
    Mukai, Masatoshi
    Nagahara, Akira
    Oka, Daizo
    Nakai, Yasutomo
    Takayama, Hitoshi
    Yoshioka, Toshiaki
    Hoshida, Yoshihiko
    Itatani, Hiroaki
    Nishimura, Kazuo
    Nonomura, Norio
    CANCER RESEARCH, 2011, 71
  • [2] Excision repair cross-complementing 1(ERCC1) expression in gallbladder cancer is a prognostic factor?
    Roa, I.
    De Aretxabala, X.
    Lantadilla, S.
    HISTOPATHOLOGY, 2008, 53 : 158 - 158
  • [3] The kinetics of the excision repair cross-complementing group-1 (ERCC1) gene in patients with colorectal cancer
    Merla, Amartej
    Mallick, Atrayee Basu
    Augustine, Titto A.
    Chaudhary, Imran
    Gajavelli, Srikanth
    Maitra, Radhashree
    Daroqui, Cecilia
    Aparo, Santiago
    Seetharam, Raviraja
    Rajdev, Lakshmi
    Kaubisch, Andreas
    Madajewicz, Stephan
    Negassa, Abdissa
    Mariadason, John
    Ghalib, Mohammad Haroon
    Goel, Sanjay
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Excision repair cross-complementing gene 1 (ERCC1) protein expression in colorectal cancer
    Richman, SD
    Adlard, JW
    Seymour, MT
    Quirke, P
    BRITISH JOURNAL OF CANCER, 2002, 86 : S77 - S77
  • [5] Excision Repair Cross-Complementing Group 1 May Predict the Efficacy of Chemoradiation Therapy for Muscle-Invasive Bladder Cancer
    Kawashima, Atsunari
    Nakayama, Masashi
    Kakuta, Yoichi
    Abe, Toyofumi
    Hatano, Koji
    Mukai, Masatoshi
    Nagahara, Akira
    Nakai, Yasutomo
    Oka, Daizo
    Takayama, Hitoshi
    Yoshioka, Toshiaki
    Hoshida, Yoshihiko
    Itatani, Hiroaki
    Nishimura, Kazuo
    Nonomura, Norio
    CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2561 - 2569
  • [6] Excision repair cross-complementing 1 (ERCC1) and survival in advanced bladder cancer: Confirmatory results using immunohistochemistry
    Guix, M.
    Lema, L.
    Lloreta, J.
    Rojo, F.
    Suarez, C.
    Carles, J.
    de la Cruz, J.
    Sanchez-Carbayo, M.
    Albanell, J.
    Bellmunt, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Current status of excision repair cross complementing-group 1 (ERCC1) in cancer
    Gossage, Lucy
    Madhusudan, Srinivasan
    CANCER TREATMENT REVIEWS, 2007, 33 (06) : 565 - 577
  • [8] ERCC1 (Excision repair cross-complementing 1) expression in pT2 gallbladder cancer is a prognostic factor
    Roa, Ivan
    de Aretxabala, Xabier
    Lantadilla, Soledad
    Munoz, Sergio
    HISTOLOGY AND HISTOPATHOLOGY, 2011, 26 (01) : 37 - 43
  • [9] Tagging single nucleotide polymorphisms in excision repair cross-complementing group 1 (ERCC1) and risk of primary lung cancer in a Chinese population
    Ma, Hongxia
    Xu, Liang
    Yuan, Jing
    Shao, Minhua
    Hu, Zhibin
    Wang, Feng
    Wang, Yi
    Yuan, Wentao
    Qian, Ji
    Wang, Ying
    Xun, Pengcheng
    Liu, Hongliang
    Chen, Weihong
    Yang, Lin
    Jin, Guangfu
    Huo, Xiang
    Chen, Feng
    Shugart, Yin Yao
    Jin, Li
    Wei, Qingyi
    Wu, Tangchun
    Shen, Hongbing
    Huang, Wei
    Lu, Daru
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (06): : 417 - 423
  • [10] Excision repair cross-complementing group-1 (ERCC1) induction and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin
    Rao, Devika
    Mallick, Atrayee Basu
    Augustine, Titto
    Daroqui, Cecilia
    Jiffry, Jeeshan
    Merla, Amartej
    Chaudhary, Imran
    Seetharaman, Raviraja
    Sood, Arjun
    Gajavelli, Srikanth
    Aparo, Santiago
    Rajdev, Lakshmi
    Kaubisch, Andreas
    Chuy, Jennifer
    Maitra, Radhashree
    Goel, Sanjay
    CANCER RESEARCH, 2019, 79 (13)
12345